Litigation Details for In Re: Opana ER Antitrust Litigation (N.D. Ill. 2014)
✉ Email this page to a colleague
In Re: Opana ER Antitrust Litigation (N.D. Ill. 2014)
| Docket | ⤷ Sign Up | Date Filed | 2014-12-12 |
| Court | District Court, N.D. Illinois | Date Terminated | 2022-07-01 |
| Cause | 28:1331 Federal Question | Assigned To | Matthew F. Kennelly |
| Jury Demand | Defendant | Referred To | |
| Parties | DIRECT PURCHASER PLAINTIFFS | ||
| Patents | 6,022,539; 6,228,398; 6,294,195; 6,495,155; 7,229,636; 7,276,250; 7,404,489; 7,718,640; 7,811,560; 7,851,482; 7,879,349; 8,003,353; 8,075,872; 8,114,383; 8,192,722; 8,309,060; 8,309,122; 8,329,216; 8,338,395; 8,808,737; 8,871,779; 8,940,714; 9,119,876; 9,295,657; 9,375,478; 9,415,007; 9,687,526; 9,744,209; 9,744,239; 9,750,785; 9,937,223; RE39,941 | ||
| Attorneys | Russell A. Chorush | ||
| Firms | Smith Segura Raphael & Leger, LLP | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in In Re: Opana ER Antitrust Litigation
Details for In Re: Opana ER Antitrust Litigation (N.D. Ill. 2014)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 0000-00-00 | External link to document | |||
| 2015-05-04 | 102 | for what ultimately issued as U.S. Patent No. 7,276,250 patent entitled “Sustained release formulations…the Orange Book patents because: (1) no patents exist on the brand drug; (2) the patents have expired;…artificial act” of patent infringement, permitting the patent owner to file a patent infringement suit…ER. This patent is expected to provide patent protection until November 2023. The new patent will be listed…limitations on the types of patents that can be listed. Only drug substance patents (active ingredient), drug | External link to document | |
| 2016-02-10 | 151 | patent”), No. 5,662,933 (the “‘933 patent”), and No. 7,276,250 …purchased the rights to four patents — U.S. Patent No. 5,128,143 (the “143 patent”), No. 5,958,456 (the …of any unexpired patents listed in the Orange Book; or (IV) that any unexpired patents listed in the Orange…artificial act” of patent infringement, permitting the brand company to file a patent infringement suit… ‘143 patent in the Orange Book as covering Opana ER, and later added the ‘456 and ‘933 patents. | External link to document | |
| 2016-02-25 | 162 | “‘456 patent”), No. 5,662,933 (the “‘933 patent”), and No. 7,276,250 (the “‘250 patent”) (collectively… rights to four patents — U.S. Patent No. 5,128,143 (the “‘143 patent”), No. …expiration of the Penwest Patents, and Endo sued each for patent infringement. RAC ¶¶ 84-109…enforceability of the ‘933 and ‘456 patents, as well as the ‘250 patent, which Endo had not even accused…agreement to settle ongoing patent infringement Case: 1:14-cv-10150 Document | External link to document | |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
